Inhibrx BiosciencesINBX
那斯達克 · USD
67.13
+4.78
(+7.67%)
收盤 04/09 03:59 (UTC+8)
04/09 03:59 (UTC+8)
Inhibrx BiosciencesINBX
67.13
+4.78
(+7.67%)
財務數據
損益表
- 0.00
- 0.02
- -
- 0.00
- -
- 0.00
- -
- 0.01
- -
- -
- 296.67
- 1273.11
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | - | - | 1,300 | - | 100 | - | 100 | - | 1,634 | 119 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | 1,300 | - | 100 | - | 100 | - | 1,634 | 119 |
營業費用 | 30,923 | 33,812 | 28,689 | 42,901 | 50,028 | 46,797 | 160,998 | 73,825 | 89,923 | 45,946 |
研發費用 | 25,349 | 28,535 | 22,267 | 36,877 | 33,367 | 38,893 | 67,632 | 63,851 | 82,091 | 38,057 |
推銷及管理費用 | 5,574 | 5,277 | 6,422 | 6,024 | 16,661 | 7,904 | 93,366 | 9,974 | 7,832 | 7,889 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -30,923 | -33,812 | -27,389 | -42,901 | -49,928 | -46,797 | -160,898 | -73,825 | -88,289 | -45,827 |
其他收入及費用 | 1,274 | 1,737 | 1,878 | 2,279 | 2,063 | 2,933 | - | 3,245 | 4,538 | 2,189 |
利息費用 | 3,185 | 3,181 | 3,141 | 2,689 | - | - | 5,361 | 8,130 | 8,223 | 8,149 |
稅前純益 | -32,834 | -35,256 | -28,652 | -43,311 | -47,865 | -43,864 | 1,858,013 | -78,710 | -91,974 | -51,787 |
所得稅 | - | - | 2 | - | - | - | 2 | - | -4 | 2 |
稅後純益 | -32,834 | -35,256 | -28,654 | -43,311 | -47,865 | -43,864 | 1,858,011 | -78,710 | -93,604 | -51,789 |
基本每股稅後盈餘(元) | -2.11 | -2.28 | -1.85 | -2.80 | -3.09 | -2.84 | 127.10 | -5.53 | - | -3.64 |
稀釋每股稅後盈餘(元) | -2.11 | -2.28 | -1.85 | -2.80 | -4.47 | -5.66 | 125.48 | -1.44 | -1.82 | -1.10 |
基本平均股數(千股) | 15533.00 | 15478.00 | 15468.00 | 15468.00 | 15468.00 | 15468.00 | 14619.00 | 14241.00 | - | 14241.00 |
稀釋平均股數(千股) | 15533.00 | 15478.00 | 15468.00 | 15468.00 | 15468.00 | 15468.00 | 14807.00 | 14241.00 | - | 14241.00 |
還原基本每股稅後盈餘(元) | -2.11 | -2.28 | -1.85 | -2.80 | -3.09 | -2.84 | 127.10 | -5.53 | - | -3.64 |
還原稀釋每股稅後盈餘(元) | -2.11 | -2.28 | -1.85 | -2.80 | -4.47 | -5.66 | 125.48 | -1.44 | -1.82 | -1.10 |
還原基本平均股數(千股) | 15,533 | 15,478 | 15,468 | 15,468 | 15,468 | 15,468 | 14,619 | 14,241 | - | 14,241 |
還原稀釋平均股數(千股) | 15,533 | 15,478 | 15,468 | 15,468 | 15,468 | 15,468 | 14,807 | 14,241 | - | 14,241 |
EBITDA(千元) | -28,443 | -30,854 | -24,224 | -39,414 | -47,176 | -43,104 | 1,863,850 | -68,978 | -83,840 | -42,095 |